Schering-Plough And Organon Japanese Subsidiaries To Consolidate Business
This article was originally published in PharmAsia News
Japanese subsidiaries of Schering-Plough and Organon Bioscience, which merged last November, Schering-Plough K.K. and Organon Japan announced June 17 the companies will consolidate business starting July 1. The new company will have headquarters in Osaka and marketing headquarters in Tokyo. Schering-Plough K.K. has sales of ¥79.3 billion and Organon has sales of ¥21 billion. Schering-Plough President Masao Torii will become president of new company. (Click here for more - Japanese language)
You may also be interested in...
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.
US regulators refused to accept the file for one of Y-mAbs's neuroblasoma drugs – omburtamab – in October but have given the green light to a second one, naxitamab.